Breaking News: Embarking on a Global Adventure! 🌍✈️
There are 2 main oncology societies in the world that bring together the best oncologists and cancer scientists: the European Society For Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO). Every year they organize the most prestigious conferences where the latest knowledge, innovations and breakthroughs in cancer research are presented to create the latest guidelines/recommendations for the treatment of cancer patients. If you are developing an innovative diagnostics or drug against cancer, you want to present the results of your work at ESMO and ASCO conferences, congresses or annual meetings.
And we, MultiplexDX International, did it! We have been selected for the ESMO breast cancer conference, which will take place in Berlin this May and also for the prestigious ASCO annual meeting in Chicago, USA this June. Our abstracts have passed the strict scientific selection will get a chance to presented. We will have the opportunity to present our research and innovative diagnostic test, Multiplex8+, to ten thousand oncologists and scientists from all over the world. Moreover, both of our abstracts will be published in a collection of abstracts that will be available to all members of ESMO and ASCO, and thus an even wider professional public will learn about our Multiplex8+.
We've made significant strides in spreading awareness about our groundbreaking test and making it accessible to breast cancer patients worldwide. This marks just the beginning of a series of promising developments unfolding this year. Keep your fingers crossed for more good news ahead! 🤞 Congrats Pavol Cekan & Evan Paul
We also thank our investors: Neulogy Ventures and Crowdberry.
